key: cord-0930159-xtudcufl
authors: Hassan, Ansar; Arora, Rakesh C.; Lother, Sylvain A.; Adams, Corey; Bouchard, Denis; Cook, Richard; Gunning, Derek; Lamarche, Yoan; Malas, Tarek; Moon, Michael; Ouzounian, Maral; Rao, Vivek; Rubens, Fraser; Tremblay, Philippe; Whitlock, Richard; Moss, Emmanuel; Légaré, Jean-François
title: Ramping Up the Delivery of Cardiac Surgery During the COVID-19 Pandemic: A Guidance Statement from the Canadian Society of Cardiac Surgeons
date: 2020-04-29
journal: Can J Cardiol
DOI: 10.1016/j.cjca.2020.04.030
sha: b226e6fa94195f562dc8909d0e535d852e11a687
doc_id: 930159
cord_uid: xtudcufl

Abstract The coronavirus disease 2019 (COVID-19) has had a profound global impact. Its rapid transmissibility has forced whole countries to adopt strict measures to contain its spread. As part of necessary pandemic planning, the majority of Canadian cardiac surgical programs have prioritized and delayed elective procedures in an effort to reduce the burden on the health care system and to mobilize resources in the event of a pandemic surge. While the number of COVID-19 cases continue to increase worldwide, new cases have begun to decline in many jurisdictions. This “flattening of the curve” has inevitably prompted discussions around re-opening of the economy, relaxing some public health restrictions and resuming non-urgent health care delivery.

transmissibility has forced whole countries to adopt strict measures to contain its spread. As part 63 of necessary pandemic planning, the majority of Canadian cardiac surgical programs have 64 prioritized and delayed elective procedures in an effort to reduce the burden on the health care 65 system and to mobilize resources in the event of a pandemic surge. While the number of 66 COVID-19 cases continue to increase worldwide, new cases have begun to decline in many 67 jurisdictions. This "flattening of the curve" has inevitably prompted discussions around re-68 opening of the economy, relaxing some public health restrictions and resuming non-urgent health 69 care delivery. 70

The following document provides a template whereby cardiac surgical programs may begin to 72 ramp up the delivery of cardiac surgery in a deliberate and graded fashion as the COVID-19 73 pandemic burden begins to ease that is guided by three principles (Figure 1 ). First, all 74 recommendations from public health authorities regarding COVID-19 containment must 75 continue to be followed to minimize disease spread, ensure patient safety, and protect health care 76 personnel. Second, patients awaiting elective cardiac surgery need to be proactively managed, 77 reprioritizing those with high risk anatomy or whose clinical status is deteriorating. Finally, case 78 volumes should be steadily increased in a mutually agreed upon fashion and must balance the 79 clinical needs of patients awaiting surgery against the overall requirements of the health care The notion of ramping up, though, is a sensitive subject. While there is a desire to re-establish 94 what society once knew as being normal, there is a reluctance to return to "business as usual". 95

Cardiac surgical programs face a similar predicament. On one hand, significant efforts have 96 been made by cardiac surgery teams to prioritize and delay elective cardiac surgery cases so that 97 health care resources, in particular critical care resources, may be liberated in order to treat those 98 most severely affected by COVID-19. On the other hand, there is growing concern about the 99 increased risk that patients with surgical cardiac disease face by being asked to wait indefinitely 100 for their life-saving procedure. 101 102 As such, decisions to re-expand surgical case volume will require thoughtful and appropriate 103 caution as we navigate through this global pandemic. There will be a need to make collaborative 104 decisions, all the while maintaining the awareness and flexibility needed to readjust our 105 escalation strategy in response to new and emerging data. It is with this in mind that the CSCS 106 has proposed the following guiding statements. Based on the expert opinions of cardiac surgical 107 and critical care leaders from across Canada, these guiding statements provide a template 8 whereby cardiac surgical programs may increase cardiac care in a deliberate and graded fashion 109 as the COVID-19 pandemic burden begins to ease. The COVID-19 pandemic has introduced challenges that cardiac surgical programs have never 207 experienced before. Elective cases have been scaled back, restricting programs to urgent and 208 emergent cases so that resources may be mobilized to care for patients with COVID-19. Wait 209 lists have grown, and those being asked to wait for surgery may be forced to experience 210 excessively prolonged wait times. In an effort to mitigate this, patients who were once deemed 211 surgical candidates have increasingly been referred for medical management or alternative 212 percutaneous therapies. Despite this, there remains a significant number of patients in whom 213 timely surgical intervention, even if during a global pandemic, outweighs the risk of further 214 delay. 215 216 It is with this in mind that the CSCS has postulated the aforementioned guiding statements in an 217 effort to support cardiac surgical programs across Canada and to provide them with a template 218 upon which to formulate their plans to ramp up. As new data emerges, these guiding statements 219 may change over time given the fluidity and scope of the current pandemic. Geographic 13 differences in epidemiology and practice patterns across Canada must be acknowledged, and we 221 hope that these guiding statements will allow for the deliberate and graded increase in cardiac 222 surgical care as the COVID-19 pandemic burden begins to ease. 

Cardiac Surgery in Canada during the

Guidance Statement from the Canadian Society of Cardiac Surgeons

Variation in False Negative Rate of RT-PCR Based SARS-CoV-2

Tests by Time Since Exposure

Diagnostic Testing for Severe Acute Respiratory Syndrome-235

Related Coronavirus-2

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease 237 (COVID-19)

Initial Invasive or Conservative Strategy for Stable Coronary 239